Corpay vs WEX
CPAY and WEX side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPAY and WEX compare
Corpay is the larger company, worth 5.0 times as much as WEX ($30.3B against $6.1B).
On earnings, WEX is cheaper: it trades at 15.9× trailing earnings, against 25.4× for Corpay.
Corpay grew revenue faster over the last twelve months (21.2% versus 9.7% for WEX).
Corpay keeps more of each dollar of sales as profit, with a net margin of 23.7% compared with 14.0% at WEX.
WEX scores higher on the StockData Score (14 against 11 for Corpay), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPAY | WEX |
|---|---|---|
| Size and price | ||
| Market cap | $30.3B | $6.1B |
| Share price | $461.73 | $184.83 |
| Change, 1 year | 63.1% | 31.2% |
| Change, 5 years | 115% | 40.1% |
| Beta (5Y) | 1.09 | 0.15 |
| Employees | 12K | 6,600 |
| StockData Score | ||
| Total score | 11 | 14 (better) |
| Valuation score | 1 | 5 (better) |
| Growth score | 3 | 4 (better) |
| Performance score | 5 (better) | 4 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 25.4× | 15.9× (better) |
| P/S | 5.8× | 2.1× (better) |
| P/B | 9.2× | 5.3× (better) |
| EV/EBITDA | 11.8× | 6.0× (better) |
| P/FCF | 22.7× | – |
| PEG | 3.87 | 0.68 (better) |
| FCF yield | 4.4% (better) | −5.1% |
| Fair value | $431.88 | $322.92 |
| Margin of safety | −6.9% | 42.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 21.2% (better) | 9.7% |
| Revenue growth, 5Y average | 13.6% (better) | 11.3% |
| Net income growth (TTM) | 18.1% | 42.6% (better) |
| EPS growth (TTM) | 23.4% | 51.3% (better) |
| EPS growth, 5Y average | 13.1% | – |
| Profitability | ||
| Gross margin | – | 60.4% |
| Operating margin | 43.9% (better) | 26.6% |
| Net margin | 23.7% (better) | 14.0% |
| FCF margin | 25.5% (better) | −10.8% |
| Return on equity | 33.7% | 35.6% (better) |
| Return on invested capital | 33.7% | 46.4% (better) |
| Financial health | ||
| Debt / equity | 1.57 (better) | 4.62 |
| Net debt / EBITDA | 0.76 | 0.05 (better) |
| Interest coverage | 5.1× | – |
| Current ratio | 0.95 | 1.03 (better) |
| Altman Z-score | 1.72 (better) | 0.83 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | 7.0% (better) | 4.4% |
| Shareholder yield | 7.0% (better) | 4.4% |
| Ownership | ||
| Held by institutions | 97.8% | 121% |
| Held by insiders | 5.3% | 11.1% |
| Insider net buying, 12 months | −$146M | −$54.3M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 5.8% | 9.2% |
Go deeper
- CPAY stock overview
- CPAY income statement
- CPAY valuation and score
- WEX stock overview
- WEX income statement
- WEX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.